Kevin Xu

Kevin Xu (; born 1988 in Jinan) is a Chinese-American businessman. He is the chief executive officer and chairman of the biotechnology company Mebo focusing on "regenerative medicine". He also is CEO of Skingenix, Inc, and an investor in LA Weekly.

Early life and personal life Xu was born in 1988 in Jinan to Lily Li and Rongxiang Xu. When he was eight years old, Xu moved to the United States for his studies. He attended the University of Southern California, where he received a neuroscience degree. In 2023, a search in the California company register showed roughly 12 "Mebo"-named companies such as Mebo International, Mebo Capital and Mebo Fortune that were owned by Xu and his mother. a botanical drug development company that has sponsored clinical test trials to test the effectiveness of MEBO products in healing foot ulcers and burns. Xu has stated that "Skingenix is the only company in the entire US that is authorized to use the human body regeneration system techniques...Being the pioneer in the industry, we are not bound by any guidelines, as there is perfectly no guidelines for the botanical drugs."

LA Weekly In October 2017, Xu became an investor in LA Weekly, along with David Welch, Brian Calle, and others.